Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus GG in Pediatric Ulcerative Colitis
NCT00895336Phase 2Withdrawn
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Mar 2011
- Primary completion
- Mar 2012
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Lactobacillus rhamnosus GG in ulcerative colitis (UC), sponsored by Cincinnati Children's Hospital Medical Center. Planned start Mar 2011; status: withdrawn.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00895336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00895336.